Literature DB >> 9606468

Phenotypic involvement in females with the FMR1 gene mutation.

J E Riddle1, A Cheema, W E Sobesky, S C Gardner, A K Taylor, B F Pennington, R J Hagerman.   

Abstract

Fragile X syndrome is the most common from of inherited mental retardation. Approximately half of females with the full mutation have significant cognitive deficits, whereas females with the premutation do not. Phenotypic effects seen in 281 females (IQs from 64 to 139) were analyzed. Results showed that females with the full mutation differ significantly from controls on selected anthropometric measurements, physical index score, and various behavioral features. Females with the premutation differed significantly from controls in regards to a few anthropometric measurements and the physical index score but not in behavioral features. These results suggest that phenotypic effects of the FMR1 mutation are not only common in females with the full mutation, but in females with the premutation as well.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606468     DOI: 10.1352/0895-8017(1998)102<0590:piifwt>2.0.co;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  30 in total

1.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  No association between FMR1 premutations and multiple system atrophy.

Authors:  Ichiro Yabe; Hiroyuki Soma; Asako Takei; Naoto Fujik; Hidenao Sasaki
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

3.  Newborn screening and cascade testing for FMR1 mutations.

Authors:  Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

Review 4.  Fragile X-associated disorders: a clinical overview.

Authors:  Anne Gallagher; Brian Hallahan
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

Review 5.  Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Authors:  John A Tsiouris; W Ted Brown
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  Aging in fragile X syndrome.

Authors:  Agustini Utari; Evan Adams; Elizabeth Berry-Kravis; Alyssa Chavez; Felicia Scaggs; Lily Ngotran; Antoniya Boyd; David Hessl; Louise W Gane; Flora Tassone; Nicole Tartaglia; Maureen A Leehey; Randi J Hagerman
Journal:  J Neurodev Disord       Date:  2010-05-12       Impact factor: 4.025

8.  Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.

Authors:  Catalina García-Nonell; Eugenia Rigau Ratera; Susan Harris; David Hessl; Michele Y Ono; Nicole Tartaglia; Emily Marvin; Flora Tassone; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

Review 9.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

10.  The neural basis of auditory temporal discrimination in girls with fragile X syndrome.

Authors:  Scott S Hall; Elizabeth Walter; Elena Sherman; Fumiko Hoeft; Allan L Reiss
Journal:  J Neurodev Disord       Date:  2009-03       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.